Altamira Therapeutics Ltd... (CYTO)
NASDAQ: CYTO
· Real-Time Price · USD
0.30
0.00 (0.00%)
At close: Jan 16, 2025, 10:00 PM
Altamira Therapeutics Income Statement
Financials in CHF. Fiscal
year is
January - December.
| Fiscal Year | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 52.73K | 52.73K | n/a | -458.69K | 145.4K | 145.4K | n/a | n/a | n/a | n/a |
Cost of Revenue | 106.09K | 106.09K | n/a | 125.81K | 596.12K | 596.12K | n/a | n/a | n/a | n/a |
Gross Profit | -53.36K | -53.36K | n/a | -584.5K | -450.72K | -450.72K | n/a | n/a | n/a | n/a |
Operating Income | -2.29M | -2.29M | 5.92M | -3.13M | -4.21M | -4.21M | 5.51M | -4.39M | -3.23M | -3.23M |
Interest Income | 263.14 | 266.37K | 146.2K | 267.03K | 188.42K | 188.42K | 192.35K | 7.01K | 86.23K | 86.23K |
Pretax Income | -2.71M | -2.71M | -781.79K | -9.59M | -4.14M | -4.14M | 5.09M | -5.14M | -3.38M | -3.38M |
Net Income | -2.71M | -2.71M | -802.08K | -9.61M | -4.12M | -4.12M | 5.22M | -5.15M | -3.38M | -3.38M |
Selling & General & Admin | 1.16M | 1.16M | 1.72M | 907.92K | 2.1M | 2.1M | 1.07M | 1.68M | 1.53M | 1.53M |
Research & Development | 1.13M | 1.13M | 3M | 8.06M | 1.78M | 1.78M | 2.67M | 2.48M | 1.7M | 1.7M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 2.39M | 2.39M | 635.59K | 8.74M | 3.5M | 3.5M | 4.9M | 5.13M | 3.3M | 3.3M |
Interest Expense | 584.37K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | 83.47K | 83.47K | 2.24M | 122.25K | 1.07M | 1.07M | 969.69K | 488.61K | 260.5K | 260.5K |
Cost & Expenses | 2.49M | 2.49M | 635.59K | 8.87M | 4.1M | 4.1M | 4.9M | 5.13M | 3.3M | 3.3M |
Income Tax Expense | 5.3K | 5.3K | 20.29K | 17.88K | 23.04K | 23.04K | 123.43K | 16.13K | 5.32K | 5.32K |
Shares Outstanding (Basic) | 209.96K | 209K | 277.08K | 48.09K | 38.74K | 38.74K | 31.65K | 34.36K | 31.14K | 31.14K |
Shares Outstanding (Diluted) | 209.96K | 209.96K | 277.08K | 4.53K | 38.74K | 38.74K | 660.00 | 1.32K | 31.14K | 31.14K |
EPS (Basic) | -12.91 | -12.97 | -2.89 | -199.86 | -106.32 | -106.32 | 164.89 | -149.92 | -108.47 | -108.47 |
EPS (Diluted) | -12.91 | -12.91 | -2.89 | -2.12K | -106.32 | -106.32 | 7.91K | -3.91K | -108.47 | -108.47 |
EBITDA | -412.05K | -412.05K | 5.97M | -3.13M | -4.21M | -4.21M | 5.52M | -4.38M | -3.22M | -3.22M |
EBIT | -2.12M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Depreciation & Amortization | 2.29M | 2.29M | 45.97K | 222.00 | 222.00 | 222.00 | 11.5K | 11.5K | 11.82K | 11.82K |